MUFG Securities EMEA plc Boosts Stake in Cardinal Health, Inc. $CAH

MUFG Securities EMEA plc raised its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 4,501.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 210,340 shares of the company’s stock after acquiring an additional 205,769 shares during the period. MUFG Securities EMEA plc owned approximately 0.09% of Cardinal Health worth $43,225,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Holderness Investments Co. purchased a new stake in Cardinal Health during the fourth quarter valued at about $229,000. Norges Bank purchased a new stake in Cardinal Health during the fourth quarter valued at about $790,344,000. Coyle Financial Counsel LLC grew its position in Cardinal Health by 19.2% during the fourth quarter. Coyle Financial Counsel LLC now owns 1,621 shares of the company’s stock valued at $333,000 after acquiring an additional 261 shares during the period. Cornerstone Select Advisors LLC grew its position in Cardinal Health by 9.2% during the fourth quarter. Cornerstone Select Advisors LLC now owns 16,168 shares of the company’s stock valued at $3,323,000 after acquiring an additional 1,368 shares during the period. Finally, Eurizon Capital SGR S.p.A. purchased a new stake in Cardinal Health during the fourth quarter valued at about $16,637,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Performance

NYSE:CAH opened at $196.57 on Friday. Cardinal Health, Inc. has a one year low of $137.75 and a one year high of $233.60. The business’s 50-day simple moving average is $203.52 and its 200 day simple moving average is $208.79. The stock has a market cap of $46.04 billion, a price-to-earnings ratio of 30.06, a price-to-earnings-growth ratio of 1.17 and a beta of 0.53.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. During the same quarter in the previous year, the firm posted $2.35 earnings per share. The company’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, equities research analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be paid a $0.5158 dividend. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s payout ratio is presently 31.19%.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the company. UBS Group set a $260.00 price target on Cardinal Health and gave the company a “buy” rating in a research report on Friday, February 6th. Morgan Stanley boosted their price target on Cardinal Health from $245.00 to $255.00 and gave the company an “overweight” rating in a research report on Tuesday, April 28th. Argus upped their target price on Cardinal Health from $232.00 to $248.00 and gave the stock a “buy” rating in a research report on Wednesday, February 11th. Wells Fargo & Company decreased their target price on Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Finally, William Blair started coverage on Cardinal Health in a research report on Tuesday, April 28th. They issued an “outperform” rating for the company. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and a consensus target price of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.